A head‐to‐head comparison of risankizumab and ixekizumab for genital psoriasis: a real‐life, 24‐week, prospective study
Elena Sotiriou, Katerina Bakirtzi, Ilias Papadimitriou, Aikaterini Tsentemeidou, Polychronia Eftychidou, Vlassios Eleftheriadis, Aimilios Lallas, D. Ioannides, Efstratios Vakirlis
Abstract
None to declare. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Topics & Concepts
MedicineIxekizumabHead (geology)PsoriasisDermatologyPediatricsGeologyPsoriatic arthritisGeomorphologySecukinumabPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesAsthma and respiratory diseases